A rapidly changing healthcare landscape calls for an agile ecosystem of service providers. Healthcare innovation and transformation proliferates, increasing the need for new regulation and demanding that regulators reconcile competing priorities. How can optimal delivery be achieved at increased speed, while minimising risks to patient safety and wellbeing?
In Europe and Singapore, regulators navigate this dilemma by creating sandboxes. These permit early entrants to test novel care and business models within controlled environments. Regulators, in turn, benefit from participants’ insights into emerging risks and get the opportunity to co-create and trial solutions before mass roll-out takes place.
This outcome-based approach helps reduce time to market, allows for product- and market-testing, tests viability of underlying technology and models, and helps the development of improved consumer safeguards.
This January, EuroCham explores member approaches to healthcare innovation, the challenges they face in product development and commercialisation, and the growing need for (and potential benefits of) launching regulatory sandboxes as test-beds for the innovation and roll-out of healthcare solutions.
4:20 pm Webinar waiting room opens
4:30 pm Welcome Address by Mr Anbu SRINIVASAN, Chair of EuroCham Healthcare Committee
4:35 pm Introductory Remarks & Introduction of Companies by Ms Nele CORNELIS, Executive Director
4:40 pm Presentations
5:15 pm Panel Discussion and Q&A moderated by Mr Mohit GROVER
5:55 pm Closing remarks
Professor John CW Lim is founding Executive Director of the Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS), inaugural Chairman of the Consortium for Clinical Research & Innovation Singapore (CRIS), Senior Advisor at Singapore’s Ministry of Health (MOH), and Policy Core Lead at the SingHealth Duke-NUS Global Health Institute (SDGHI). He is a Professor of Practice at Duke-NUS and the NUS Saw Swee Hock School of Public Health.
Formerly Chief Executive Officer of Singapore’s Health Sciences Authority and Deputy Director of Medical Services (Industry & Research Matters) in MOH, Professor Lim has also held other senior positions in Singapore’s Health and Education ministries. His current roles promote capacity building and scientific excellence for health product regulation, health policies, and systems in Southeast Asia and the Asia-Pacific.
Professor Lim is a member of the Singapore Food Agency Board, APEC Life Sciences Innovation Forum’s Executive Board, Davos Alzheimer’s Collaborative Leadership Group, US Pharmacopoeia (USP) Council of the Convention as Asia-Pacific Chapter Chair, USP Quality Institute’s Advisory Group, Centre for Innovation in Regulatory Science’s Scientific Advisory Council, and St Andrew’s Mission Hospital Board.
Jek started his career in leukaemia research with NUS and has more than a decade of experience in various roles within the pharmaceutical and medical device industries. Jek spent the last 4 years as Director of Market Access and Personalized Healthcare in Roche and is a passionate servant leader building highly engaged teams driven by a singular purpose to enable access to precision medicine in Singapore. Jek graduated with a BSc in Biomedical Science, and holds an executive MBA and graduate diploma in Strategic Marketing.
Andrew joined Prudential Corporation Asia as Chief Health Officer in January 2018. Andrew has over 30 years of international experience in executive management positions across Asia, Australia, the Middle East, and Europe in the insurance and healthcare industry.
Prior to joining PCA, Andrew was the CEO, Asia Pacific of Munich Health from 2014 to 2017, based in Singapore. Prior to that, Andrew held a number of senior executive positions within Bupa in Asia and the UK. The latest position he had with Bupa was the CEO of Bupa Thailand from 2008 to 2014.
Andrew is a Chartered Accountant and he holds a Master of Commerce degree from the University of New South Wales, Australia.
Mohit is an Executive Director in Deloitte SEA and leads the Life Sciences and Healthcare industry. With 20 years of experience in Consulting and Life Sciences industries, he possesses in-depth expertise in enabling business growth strategies, strategic risk management, and large scale transformations in Commercial, Finance and IT functions.
Prior to joining Deloitte Mohit held regional and global leadership positions in AstraZeneca, a global Pharmaceutical company. Mohit led initiatives across a range of strategic topics including innovation in commercial selling models, shared services, and enterprise applications. His experience will prove invaluable in helping organizations tap into the market growth potential in South East Asia and address areas of building organization capabilities, market access, regulatory compliance, and risk management.
Student tickets are available for this event.
Students from partnering universities are invited to join, free of charge. Partnering universities; NUS, NTU, SMU, EDHEC, ESSEC & INSEAD.
There are limited student tickets available and are subject to correct registration details.
- Please sign up with your university-issued email address
- Enter your institution under “company”
- Enter your major/ programme under “designation”
- Select “Complimentary Student Ticket”
Registration Guidelines –
Please follow these simple steps for easy registration to our webinar.
Step 1: Register below. You will receive an automated registration confirmation email from EuroCham.
Step 2: Prior to the event, a Zoom link will be sent if payment has been received. (Payment by PayPal, PayNow/ PayLah/ QR Code preferred). Please watch out for this second email.
Step 3: Using the link provided in the second email, click on the link 15 minutes prior to the start of the event.
Step 4: We will only admit attendees whose Zoom profiles match their registration names, so please make sure that your Zoom profile corresponds with your registration name.
Thank you for your understanding.
Kindly note that there are limited seats available, registration is binding and payment is non-refundable. The organisers reserve the right to change the programme content without giving prior notification or any reasons thereof.